Available Technologies
# of Displayed Technologies: 1 / 1
Categories
.png)
Enhanced Immunogenicity of a Modified Respiratory Syncytial Virus Vaccine with Mutations in One or Both Non-Structural Proteins
TS-000132 — Mutation of the RSV NS1/2 proteins to attenuate the virus and boost immunogenicity
Respiratory syncytial virus (RSV) is the leading cause of upper and lower respiratory tract infections in infants and young children, and the most common cause of bronchiolitis and pneumonia in children younger than 1-year of age. A vaccine does not exist in part because RSV non-structural protein g…
- College:
- Inventors: Peeples, Mark; Flano, Emilio; Mejias, Asuncion; Ramilo, Octavio; Teng, Michael Nan-hao (Mark)
- Licensing Officer: Corris, Andrew
